The persistence of high levels of circulating CD8+ T-cells or a low CD4/CD8 ratio translates into immunosenescence and heightened immune activation (2) and has been associated with an excess risk of non-AIDS comorbidities and higher all-cause mortality in people living with HIV (PLHIV) receiving ART (2–4). This evidence concerns the gene CD8A and AIDS.